This inventor holds 3 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: The Innovative Contributions of Noam Levin
Introduction
Noam Levin is a prominent inventor based in Rockville, MD (US). He has made significant contributions to the field of medical research, particularly in the development of T cell receptors. With a total of 3 patents to his name, Levin's work has the potential to impact cancer treatment and immunotherapy.
Latest Patents
Levin's latest patents include groundbreaking innovations such as "HLA Class II-Restricted DQ T Cell Receptors Against RAS with G13D Mutation" and "HLA Class II-Restricted DRB T Cell Receptors Against RAS with G12V Mutation." These patents reflect his commitment to advancing the understanding and treatment of cancer through targeted immunological approaches.
Career Highlights
Noam Levin works for the United States of America, as represented by the Secretary, Department of Health and Human Services. His role in this esteemed organization allows him to contribute to vital health initiatives and research projects that aim to improve patient outcomes.
Collaborations
Levin has collaborated with notable colleagues in his field, including Steven A. Rosenberg and Frank J. Lowery, III. These partnerships enhance the scope and impact of his research, fostering innovation through shared expertise.
Conclusion
Noam Levin's work exemplifies the spirit of innovation in medical research. His patents and collaborations highlight his dedication to advancing cancer treatment through immunotherapy. The contributions of inventors like Levin are crucial for the future of healthcare and patient well-being.